Il2 Conditional Knockout mouse models

Il2 is the mouse ortholog of human IL2 and encodes a four alpha helix bundle cytokine that assembles a trimeric receptor of IL-2Ralpha, IL-2Rbeta, and the common gamma chain, activating JAK1 and JAK3 with STAT5 to control regulatory T cell fitness, effector CD8 expansion, and activation induced cell death. Because high-affinity capture depends on constitutive CD25 on regulatory T cells, interleukin 2 availability is a tolerance checkpoint, and germline Il2 or Il2ra nulls develop lethal lymphoproliferation with autoimmune hemolytic anemia and colitis rather than immunodeficiency, a phenotype that constrains any breeding scheme. Allele class should follow the endpoint: conditional deletion in CD4 T cells asks who supplies the cytokine, knockins encoding not-alpha or CD25-biased muteins model low dose interleukin 2 therapy, and humanization supports aldesleukin and engineered agonist pharmacology. Plan drivers early, since Cd4-Cre, Foxp3-Cre, and inducible CreERT2 lines give very different windows on tolerance versus antitumor expansion.

A floxed Il2 allele paired with Cre gives spatial control that whole body knockouts cannot offer. People use it to separate developmental roles from adult homeostasis, to model somatic mutations, and to match disease that begins in one organ.